Skip to main content

Ubrelvy Disease Interactions

There are 2 disease interactions with Ubrelvy (ubrogepant).

Moderate

Ubrogepant (applies to Ubrelvy) hepatic dysfunction

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Care should be exercised when using ubrogepant in patients with severe hepatic impairment. Dose adjustment is recommended for these patients. No dose adjustment is recommended for patients with mild or moderate hepatic impairment.

References

  1. (2019) "Product Information. Ubrelvy (ubrogepant)." Allergan Inc
Moderate

Ubrogepant (applies to Ubrelvy) renal impairment

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction

It is recommended to avoid the use of ubrogepant in patients with end-stage renal disease (CrCl <15 mL/min). No dosing recommendations can be made for these patients. A dose adjustment is recommended for patients with severe renal impairment (CrCl 15-29 mL/min). No dose adjustments are recommended for patients with mild or moderate renal impairment.

References

  1. (2019) "Product Information. Ubrelvy (ubrogepant)." Allergan Inc

Ubrelvy drug interactions

There are 218 drug interactions with Ubrelvy (ubrogepant).

Ubrelvy alcohol/food interactions

There is 1 alcohol/food interaction with Ubrelvy (ubrogepant).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.